相关实验视频
Updated: Jan 16, 2026

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.2K
不同的普雷尼松起始剂量对于系统性皮质类固醇-先天的退伍军人与活跃的类固醇症
Nadera J Sweiss1, Zane Z Elfessi1, Mandeep K Sidhu1,2
1University of Illinois Chicago.
概括
肺部病学家坚持对型硬化症患者的普雷尼松剂量指南,而其他专家可能会开较低的初始剂量. 这项研究突出了对类固醇的皮质类固醇治疗开始的差异.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 石病是一种复杂的颗粒性疾病,会影响多个器官.
- 治疗萨尔科病的决定取决于疾病的严重程度和器官的参与.
- 目前的指导方针建议每天给新诊断的类固醇患者服用20-40毫克普雷迪尼松.
研究的目的:
- 为了评估新诊断的类菌病患者遵守普得尼松剂量指南.
- 为了比较肺病学家和其他专家处方的初始普得尼松剂量.
- 为了识别沙尔科病的皮质类固醇治疗开始的潜在变化.
主要方法:
- 在VA医疗中心 (2014-2023) 进行了对萨尔科伊多सिस患者的回顾性评估.
- 纳入标准:系统性皮质类固醇未使用过的患有活跃类固醇症的患者.
- 收集的数据:患者人口统计学,处方者的专业,以及每日初始的普得尼松剂量.
主要成果:
- 分析了68名患者,76%是黑人,91%是男性.
- 肺病学家在推的20-40毫克范围内 (中位数为35毫克) 处方普雷迪尼松.
- 非肺病学家 (例如,初级保健) 经常处方较低的剂量 (中位数为17.5毫克;P <.05).
结论:
- 萨尔科发病的初始普雷尼松剂量在肺病学家和其他专家之间有所不同.
- 需要进一步的研究来了解剂量变化的原因.
- 这些不同的初始剂量对长期沙病结局的影响需要研究.
相关概念视频
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166
Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Dosage Regimen: Multiple Oral Dosage
229
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
229
Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.3K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.3K
COPD: Management Using Bronchodilators and Corticosteroids
726
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
726
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K

